InsidersTradesSigma
Follow the Arovella Therapeutics Limited stock price and the full management transaction log of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Arovella Therapeutics Limited has recorded 3 reports. Market capitalisation: €72.5m. The latest transaction was filed on 9 June 2026 (Purchase). Among the most active insiders: Andrew Nash. Every trade is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€8,158
1 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,688 of 29,064 companies
34.8
score / 100
Value16
Quality53
FCF yld-9.6%
Earn yld-9.5%
EV/EBITDA·
ROE-40%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2026
Declarations3 total
200,000 shares@ A$0.0670.0000% mcap100.0% of flowShareASXISIN AU0000182784ASX:2924-03098698-3A695000
ShareASXISIN AU0000182784ASX:2924-03087734-3A692891
●
11ASX ↗
ShareASXISIN AU0000182784ASX:2924-03085488-3A692486
3 of 3 declarations
关于 Arovella Therapeutics Limited
Arovella Therapeutics Limited 是一家澳大利亚生物制药公司，专注于开发治疗严重疾病的创新疗法。该公司专门从事基于先进技术的疗法研究与开发。